Genentech (DNA) drug numbers: Avastin $731M vs. $749M consensus. Rituxan $677M vs. $681M....

|By:, SA News Editor
Genentech (DNA) drug numbers: Avastin $731M vs. $749M consensus. Rituxan $677M vs. $681M. Herceptin $336M vs. $364M. Lucentis $236M vs. $228M. Tarceva $118M vs. $121M. Raptiva $25M vs. $28M. (PR)